Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?

Achten, Anouk; Muller, Steven A; Zwetsloot, Peter-Paul; Michels, Michelle; van der Meer, Peter; Nienhuis, Hans L A; van der Meer, Manon G; van Empel, Vanessa P M; Oerlemans, Marish I F J; Knackstedt, Christian

doi:https://doi.org/10.1080/14779072.2025.2463333

Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?

DSpace/Manakin Repository

Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?

Achten, Anouk; Muller, Steven A; Zwetsloot, Peter-Paul; Michels, Michelle; van der Meer, Peter; Nienhuis, Hans L A; van der Meer, Manon G; van Empel, Vanessa P M; Oerlemans, Marish I F J; Knackstedt, Christian

(2025) Expert Review of Cardiovascular Therapy, volume 23, issue 1-2, pp. 1 - 4

(Editorial)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: ATTR, amyloid, amyloidosis, cardiomyopathy, genetic, Internal Medicine, Cardiology and Cardiovascular Medicine

DOI: https://doi.org/10.1080/14779072.2025.2463333

ISSN: 1477-9072

Publisher: Taylor and Francis Ltd.

(Peer reviewed)